Logo image of EXA.PA

EXAIL TECHNOLOGIES (EXA.PA) Stock Fundamental Analysis

EPA:EXA - Euronext Paris - Matif - FR0000062671 - Common Stock - Currency: EUR

47.25  +1.85 (+4.07%)

Fundamental Rating

3

EXA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 106 industry peers in the Machinery industry. Both the profitability and financial health of EXA have multiple concerns. EXA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year EXA has reported negative net income.
EXA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXA reported negative net income in multiple years.
Of the past 5 years EXA 4 years had a positive operating cash flow.
EXA.PA Yearly Net Income VS EBIT VS OCF VS FCFEXA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

EXA's Return On Assets of -0.44% is on the low side compared to the rest of the industry. EXA is outperformed by 68.87% of its industry peers.
EXA has a worse Return On Equity (-3.04%) than 72.64% of its industry peers.
EXA's Return On Invested Capital of 2.85% is on the low side compared to the rest of the industry. EXA is outperformed by 66.98% of its industry peers.
EXA had an Average Return On Invested Capital over the past 3 years of 2.19%. This is significantly below the industry average of 8.60%.
The last Return On Invested Capital (2.85%) for EXA is above the 3 year average (2.19%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROIC 2.85%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
EXA.PA Yearly ROA, ROE, ROICEXA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

With a Operating Margin value of 6.05%, EXA perfoms like the industry average, outperforming 50.94% of the companies in the same industry.
EXA's Operating Margin has improved in the last couple of years.
The Gross Margin of EXA (55.36%) is better than 77.36% of its industry peers.
EXA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.05%
PM (TTM) N/A
GM 55.36%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
EXA.PA Yearly Profit, Operating, Gross MarginsEXA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXA is destroying value.
The number of shares outstanding for EXA has been reduced compared to 1 year ago.
The number of shares outstanding for EXA has been increased compared to 5 years ago.
Compared to 1 year ago, EXA has a worse debt to assets ratio.
EXA.PA Yearly Shares OutstandingEXA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EXA.PA Yearly Total Debt VS Total AssetsEXA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

EXA has an Altman-Z score of 1.46. This is a bad value and indicates that EXA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.46, EXA is not doing good in the industry: 62.26% of the companies in the same industry are doing better.
EXA has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as EXA would need 6.15 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.15, EXA perfoms like the industry average, outperforming 50.94% of the companies in the same industry.
A Debt/Equity ratio of 2.52 is on the high side and indicates that EXA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.52, EXA is doing worse than 89.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Altman-Z 1.46
ROIC/WACC0.43
WACC6.71%
EXA.PA Yearly LT Debt VS Equity VS FCFEXA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.25 indicates that EXA should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.25, EXA is doing worse than 71.70% of the companies in the same industry.
EXA has a Quick Ratio of 1.25. This is a bad value and indicates that EXA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EXA (0.93) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.93
EXA.PA Yearly Current Assets VS Current LiabilitesEXA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for EXA have decreased strongly by -128.05% in the last year.
Looking at the last year, EXA shows a quite strong growth in Revenue. The Revenue has grown by 15.32% in the last year.
The Revenue has been growing slightly by 6.32% on average over the past years.
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%

3.2 Future

EXA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 88.61% yearly.
Based on estimates for the next years, EXA will show a small growth in Revenue. The Revenue will grow by 7.06% on average per year.
EPS Next Y1276.91%
EPS Next 2Y447.16%
EPS Next 3Y235.58%
EPS Next 5Y88.61%
Revenue Next Year19.58%
Revenue Next 2Y21.56%
Revenue Next 3Y18.65%
Revenue Next 5Y7.06%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXA.PA Yearly Revenue VS EstimatesEXA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
EXA.PA Yearly EPS VS EstimatesEXA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 53.65, EXA can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, EXA is valued a bit more expensive than the industry average as 73.58% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of EXA to the average of the S&P500 Index (21.38), we can say EXA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 53.65
EXA.PA Price Earnings VS Forward Price EarningsEXA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150 -200

4.2 Price Multiples

68.87% of the companies in the same industry are more expensive than EXA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.52
EV/EBITDA N/A
EXA.PA Per share dataEXA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

EXA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXA's earnings are expected to grow with 235.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y447.16%
EPS Next 3Y235.58%

0

5. Dividend

5.1 Amount

No dividends for EXA!.
Industry RankSector Rank
Dividend Yield N/A

EXAIL TECHNOLOGIES

EPA:EXA (4/30/2025, 5:28:23 PM)

47.25

+1.85 (+4.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)07-23 2025-07-23
Inst Owners20.98%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap823.10M
Analysts82.86
Price Target45.67 (-3.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-41.67%
DP-10.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)68.96%
PT rev (3m)86.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.64%
EPS NY rev (3m)29.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.32%
Revenue NY rev (3m)-1.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 53.65
P/S 2.21
P/FCF 14.52
P/OCF 9.01
P/B 6.86
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)0.88
Fwd EY1.86%
FCF(TTM)3.25
FCFY6.89%
OCF(TTM)5.25
OCFY11.1%
SpS21.42
BVpS6.88
TBVpS-17.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROCE 3.88%
ROIC 2.85%
ROICexc 3.14%
ROICexgc 14.88%
OM 6.05%
PM (TTM) N/A
GM 55.36%
FCFM 15.2%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
ROICexc(3y)2.4%
ROICexc(5y)3.68%
ROICexgc(3y)9.45%
ROICexgc(5y)12.41%
ROCE(3y)2.98%
ROCE(5y)3.95%
ROICexcg growth 3Y18.91%
ROICexcg growth 5Y18.06%
ROICexc growth 3Y-17.84%
ROICexc growth 5Y1.29%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 9.3%
Interest Coverage 1.55
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.93
Altman-Z 1.46
F-Score5
WACC6.71%
ROIC/WACC0.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.56%
Cap/Sales(5y)12.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
EPS Next Y1276.91%
EPS Next 2Y447.16%
EPS Next 3Y235.58%
EPS Next 5Y88.61%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%
Revenue Next Year19.58%
Revenue Next 2Y21.56%
Revenue Next 3Y18.65%
Revenue Next 5Y7.06%
EBIT growth 1Y1338.9%
EBIT growth 3Y22.08%
EBIT growth 5Y23.35%
EBIT Next Year188.15%
EBIT Next 3Y61.04%
EBIT Next 5Y29.88%
FCF growth 1Y137.85%
FCF growth 3YN/A
FCF growth 5Y40.49%
OCF growth 1Y64.25%
OCF growth 3YN/A
OCF growth 5Y26.69%